Savci-Heijink, C. D. http://orcid.org/0000-0003-1220-0061
Halfwerk, H.
Hooijer, G. K. J.
Koster, J.
Horlings, H. M.
Meijer, S. L.
van de Vijver, M. J.
Funding for this research was provided by:
Center for Translational Molecular Medicine (BreastCARE)
Article History
Received: 14 September 2018
Accepted: 6 December 2018
First Online: 4 January 2019
Compliance with ethical standards
:
: Author M. J. van de Vijver holds consultant/advisory role in Le Roche and MammaPrint, Agendia (inventor patent). M. J. van de Vijver has also received research grants from Merck Sharp & Dohme. All the other authors declared that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors. This study material was strictly handled after coding of the data according to national ethical guidelines of ‘Code for Proper Secondary Use of Human Tissue’ developed by Federation of Medical Societies (FMWV) in the Netherlands [CitationRef removed]. The entire study protocol was approved by the Medical Ethical Committee of the Academic Medical Center. The need for obtaining informed consent was waived by this committee.